Maurin, Wilfredo G.

HRN: 13-81-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/06/2025
09/13/2025
IV
2.25
Q6
Sepsis Secondary To Sacral Ulcer Grade 3
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines